MOTIVATION: Single-cell RNA sequencing (scRNA-seq) analysis relies heavily on effective clustering to facilitate numerous downstream applications. Although several machine learning methods have been developed to enhance single-cell clustering, most are fully unsupervised and overlook the rich repository of annotated datasets available from previous single-cell experiments. Since cells are inherently high-dimensional entities, unsupervised clustering can often result in clusters that lack biological relevance. Leveraging annotated scRNA-seq datasets as a reference can significantly enhance clustering performance, enabling the identification of biologically meaningful clusters in target datasets. RESULTS: In this article, we propose Single Cell MUlti-Source CLustering (scMUSCL), a novel transfer learning method designed to identify cell clusters in a target dataset by leveraging knowledge from multiple annotated reference datasets. scMUSCL employs a deep neural network to extract domain- and batch-invariant cell representations, effectively addressing discrepancies across various source datasets and between source and target datasets within the new representation space. Unlike existing methods, scMUSCL does not require prior knowledge of the number of clusters in the target dataset and eliminates the need for batch correction between source and target datasets. We conduct extensive experiments using 20 real-life datasets, demonstrating that scMUSCL consistently outperforms existing unsupervised and transfer learning-based methods. Furthermore, our experiments show that scMUSCL benefits from multiple source datasets as learning references and accurately estimates the number of clusters. AVAILABILITY AND IMPLEMENTATION: The Python implementation of scMUSCL is available at https://github.com/arashkhoeini/scMUSCL.

MOTIVATION: A patient's disease phenotype can be driven and determined by specific groups of cells whose marker genes are either unknown or can only be detected at late-stage using conventional bulk assays such as RNA-Seq technology. Recent advances in single-cell RNA sequencing (scRNA-seq) enable gene expression profiling in cell-level resolution, and therefore have the potential to identify those cells driving the disease phenotype even while the number of these cells is small. However, most existing methods rely heavily on accurate cell type detection, and the number of available annotated samples is usually too small for training deep learning predictive models. RESULTS: Here, we propose the method ScRAT for phenotype prediction using scRNA-seq data. To train ScRAT with a limited number of samples of different phenotypes, such as coronavirus disease (COVID) and non-COVID, ScRAT first applies a mixup module to increase the number of training samples. A multi-head attention mechanism is employed to learn the most informative cells for each phenotype without relying on a given cell type annotation. Using three public COVID datasets, we show that ScRAT outperforms other phenotype prediction methods. The performance edge of ScRAT over its competitors increases as the number of training samples decreases, indicating the efficacy of our sample mixup. Critical cell types detected based on high-attention cells also support novel findings in the original papers and the recent literature. This suggests that ScRAT overcomes the challenge of missing marker genes and limited sample number with great potential revealing novel molecular mechanisms and/or therapies. AVAILABILITY AND IMPLEMENTATION: The code of our proposed method ScRAT is published at https://github.com/yuzhenmao/ScRAT.